Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP07 - Pathology

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Type: Posters (Featured)
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      FP07.15 - Real-world ALK Testing Trends and Patterns in Patients with Advanced NSCLC in the United States

      00:00 - 00:00  |  Presenter: Christine M. Lovly

      • Abstract

      Loading...

  • +

    P11 - Health Services Research/Health Economics - Quality of Life

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P11.03 - Importance of Capturing the Patient Experience of Overall Symptoms and HRQoL Impact in Patients With ALK+ NSCLC

      00:00 - 00:00  |  Presenter: Yanyan Zhu

      • Abstract

      Loading...

  • +

    P37 - Pathology - Biomarker Testing

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P37.31 - Trends in the Detection of EGFR Exon 20 Insertions in Patients with NSCLC in the US

      00:00 - 00:00  |  Presenter: Huamao M Lin

      • Abstract

      Loading...

  • +

    P84 - Targeted Therapy - Clinically Focused - ALK

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • +

      P84.08 - First-line Brigatinib in Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer: A Network Meta-Analysis

      00:00 - 00:00  |  Presenter: Huamao M Lin

      • Abstract

      Loading...

    • +

      P84.11 - Real-World Brigatinib Dosing Patterns in Patients with Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer in the United States

      00:00 - 00:00  |  Presenter: Huamao M Lin

      • Abstract

      Loading...

  • +

    OA04 - New Data from Rare EGFR Alterations

    • 11:45 - 12:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Targeted Therapy - Clinically Focused
    • +

      OA04.03 - Mobocertinib in NSCLC With EGFR Exon 20 Insertions: Results From EXCLAIM and Pooled Platinum-Pretreated Patient Populations

      11:45 - 11:55  |  Presenter: Caicun Zhou

      • Abstract

      Loading...